TrumpRx.gov: Revolutionizing Prescription Drug Prices in America
President Trump is set to launch TrumpRx.gov, a website offering discounted prescription medications. Partnering with major drug companies, the initiative aims to cut drug prices for consumers and Medicaid, featuring agreements with companies like Eli Lilly and Novo Nordisk to reduce costs on popular medications.
President Donald Trump is preparing to introduce TrumpRx.gov, a website designed to provide American consumers access to discounted prescription drugs, according to a White House announcement.
Scheduled for unveiling during an event at the White House, Trump will be joined by CMS Administrator Dr. Mehmet Oz and Airbnb co-founder Joe Gebbia. Sixteen major pharmaceutical companies have agreed to lower prices in the U.S. as part of "most-favored nation" deals with the administration.
The agreements aim to slash prices of key drugs, including Eli Lilly and Novo Nordisk's GLP-1 weight loss medications. The TrumpRx.gov platform, powered by GoodRx, will redirect buyers to purchase options on other sites, aiming to benefit those paying out-of-pocket.
ALSO READ
Novo Nordisk Challenges Hims & Hers Over Wegovy Compounding
Novo Nordisk Challenges Rival's Cut-Price Weight Loss Pill
Novo Nordisk's Legal Battle Over Wegovy Counterfeit
Novo Nordisk Faces Unprecedented Price Pressures, Shares Plunge
Novo Nordisk Faces Investor Backlash Amid Bleak Forecast and Rising Competition

